100 related articles for article (PubMed ID: 10636514)
21. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.
Anderson KS; Wong J; Vitonis A; Crum CP; Sluss PM; Labaer J; Cramer D
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):859-68. PubMed ID: 20200435
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of DNA quantification in early epithelial ovarian carcinoma.
Valverde JJ; Martin M; García-Asenjo JA; Casado A; Vidart JA; Díaz-Rubio E
Obstet Gynecol; 2001 Mar; 97(3):409-16. PubMed ID: 11239647
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of deletion and over-expression of the p53 gene in epithelial ovarian cancer.
Ozalp SS; Yalcin OT; Basaran GN; Artan S; Kabukcuoglu S; Minsin TH
Eur J Gynaecol Oncol; 2000; 21(3):282-6. PubMed ID: 10949395
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer.
Skírnisdóttir IA; Sorbe B; Lindborg K; Seidal T
Int J Gynecol Cancer; 2011 Feb; 21(2):236-44. PubMed ID: 21270607
[TBL] [Abstract][Full Text] [Related]
26. Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis.
Robbins CL; Whiteman MK; Hillis SD; Curtis KM; McDonald JA; Wingo PA; Kulkarni A; Marchbanks PA
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2035-41. PubMed ID: 19589914
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.
Akahira JI; Yoshikawa H; Shimizu Y; Tsunematsu R; Hirakawa T; Kuramoto H; Shiromizu K; Kuzuya K; Kamura T; Kikuchi Y; Kodama S; Yamamoto K; Sato S
Gynecol Oncol; 2001 Jun; 81(3):398-403. PubMed ID: 11371128
[TBL] [Abstract][Full Text] [Related]
28. p21 and p53 in ovarian carcinoma: their combined staining is more valuable than either alone.
Geisler HE; Geisler JP; Miller GA; Geisler MJ; Wiemann MC; Zhou Z; Crabtree W
Cancer; 2001 Aug; 92(4):781-6. PubMed ID: 11550148
[TBL] [Abstract][Full Text] [Related]
29. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
30. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
31. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors of epithelial ovarian cancer in young women].
Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.
Berchuck A; Kohler MF; Hopkins MP; Humphrey PA; Robboy SJ; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC
Gynecol Oncol; 1994 Feb; 52(2):232-6. PubMed ID: 7508877
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
Boyd J; Sonoda Y; Federici MG; Bogomolniy F; Rhei E; Maresco DL; Saigo PE; Almadrones LA; Barakat RR; Brown CL; Chi DS; Curtin JP; Poynor EA; Hoskins WJ
JAMA; 2000 May; 283(17):2260-5. PubMed ID: 10807385
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
[TBL] [Abstract][Full Text] [Related]
37. Expression and clinical significance of cortactin protein in ovarian neoplasms.
Li A; Zhang L; Zhang X; Jin W; Ren Y
Clin Transl Oncol; 2016 Feb; 18(2):220-7. PubMed ID: 26243395
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the cyclin-dependent kinase inhibitor p21Cip1 in epithelial ovarian tumors of low malignant potential and adenocarcinomas.
Vassilopoulos I; Korkolopoulou P; Konstantinidou AE; Patsouris E; Eftichiadis C; Thymara I; Perdiki M; Pavlakis K; Agapitos E; Davaris PS
Histol Histopathol; 2003 Jul; 18(3):761-70. PubMed ID: 12792888
[TBL] [Abstract][Full Text] [Related]
40. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
